Screening history of cervical cancers in Emilia-Romagna, Italy: Defining priorities to improve cervical cancer screening

Paolo Giorgi Rossi, Stefania Caroli, Silvia Mancini, Priscilla Sassoli De Bianchi, Alba C. Finarelli, Carlo Naldoni, Lauro Bucchi, Fabio Falcini

Research output: Contribution to journalArticle

Abstract

Most invasive cervical cancers in industrialized countries are due to the lack of Pap test coverage, very few are due to screening failures. This study aimed at quantifying the proportion of invasive cancers occurring in nonscreened or underscreened women and that in women with a previous negative screening, that is, screening failure, during the first two screening rounds (1996-2002) and in the following rounds (2003-2008) in the Emilia-Romagna region. All cases of invasive cancers registered in the regional cancer registry between 1996 and 2008 were classified according to screening history through a record linkage with the screening programme registry. The incidence significantly decreased from 11.6/100 000 to 8.7/100 000; this decrease is due to a reduction in squamous cell cancers (annual percentage change -6.2; confidence interval: - 7.8, -4.6) and advanced cancers (annual percentage change -6.6; confidence interval: - 8.8, -4.3), whereas adenocarcinomas and microinvasive cancers were essentially stable. The proportion of cancers among women not yet invited and among nonresponders decreased over the two periods, from 45.5 to 33.3%. In contrast, the proportion of women with a previous negative Pap test less than 5 years and 5 years or more before cancer incidence increased from 5.7 to 13.3% and from 0.3 to 5.5%, respectively. Although nonattendance of the screening programme remains the main barrier to cervical cancer control, the introduction of a more sensitive test, such as the human papillomavirus DNA test, could significantly reduce the burden of disease.

Original languageEnglish
Pages (from-to)128-134
Number of pages7
JournalEuropean Journal of Cancer Prevention
Volume24
Issue number2
DOIs
Publication statusPublished - 2015

Fingerprint

Early Detection of Cancer
Uterine Cervical Neoplasms
Italy
Neoplasms
Papanicolaou Test
Registries
Human Papillomavirus DNA Tests
Confidence Intervals
Squamous Cell Neoplasms
Incidence
Developed Countries
Adenocarcinoma
History

Keywords

  • Cervical cancer
  • Human papillomavirus DNA test
  • Incidence trend
  • Mass screening
  • Pap test

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Epidemiology
  • Public Health, Environmental and Occupational Health
  • Medicine(all)

Cite this

Screening history of cervical cancers in Emilia-Romagna, Italy : Defining priorities to improve cervical cancer screening. / Rossi, Paolo Giorgi; Caroli, Stefania; Mancini, Silvia; De Bianchi, Priscilla Sassoli; Finarelli, Alba C.; Naldoni, Carlo; Bucchi, Lauro; Falcini, Fabio.

In: European Journal of Cancer Prevention, Vol. 24, No. 2, 2015, p. 128-134.

Research output: Contribution to journalArticle

@article{56a0e34df0d94bae9f01048aa201ebbc,
title = "Screening history of cervical cancers in Emilia-Romagna, Italy: Defining priorities to improve cervical cancer screening",
abstract = "Most invasive cervical cancers in industrialized countries are due to the lack of Pap test coverage, very few are due to screening failures. This study aimed at quantifying the proportion of invasive cancers occurring in nonscreened or underscreened women and that in women with a previous negative screening, that is, screening failure, during the first two screening rounds (1996-2002) and in the following rounds (2003-2008) in the Emilia-Romagna region. All cases of invasive cancers registered in the regional cancer registry between 1996 and 2008 were classified according to screening history through a record linkage with the screening programme registry. The incidence significantly decreased from 11.6/100 000 to 8.7/100 000; this decrease is due to a reduction in squamous cell cancers (annual percentage change -6.2; confidence interval: - 7.8, -4.6) and advanced cancers (annual percentage change -6.6; confidence interval: - 8.8, -4.3), whereas adenocarcinomas and microinvasive cancers were essentially stable. The proportion of cancers among women not yet invited and among nonresponders decreased over the two periods, from 45.5 to 33.3{\%}. In contrast, the proportion of women with a previous negative Pap test less than 5 years and 5 years or more before cancer incidence increased from 5.7 to 13.3{\%} and from 0.3 to 5.5{\%}, respectively. Although nonattendance of the screening programme remains the main barrier to cervical cancer control, the introduction of a more sensitive test, such as the human papillomavirus DNA test, could significantly reduce the burden of disease.",
keywords = "Cervical cancer, Human papillomavirus DNA test, Incidence trend, Mass screening, Pap test",
author = "Rossi, {Paolo Giorgi} and Stefania Caroli and Silvia Mancini and {De Bianchi}, {Priscilla Sassoli} and Finarelli, {Alba C.} and Carlo Naldoni and Lauro Bucchi and Fabio Falcini",
year = "2015",
doi = "10.1097/CEJ.0000000000000035",
language = "English",
volume = "24",
pages = "128--134",
journal = "European Journal of Cancer Prevention",
issn = "0959-8278",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Screening history of cervical cancers in Emilia-Romagna, Italy

T2 - Defining priorities to improve cervical cancer screening

AU - Rossi, Paolo Giorgi

AU - Caroli, Stefania

AU - Mancini, Silvia

AU - De Bianchi, Priscilla Sassoli

AU - Finarelli, Alba C.

AU - Naldoni, Carlo

AU - Bucchi, Lauro

AU - Falcini, Fabio

PY - 2015

Y1 - 2015

N2 - Most invasive cervical cancers in industrialized countries are due to the lack of Pap test coverage, very few are due to screening failures. This study aimed at quantifying the proportion of invasive cancers occurring in nonscreened or underscreened women and that in women with a previous negative screening, that is, screening failure, during the first two screening rounds (1996-2002) and in the following rounds (2003-2008) in the Emilia-Romagna region. All cases of invasive cancers registered in the regional cancer registry between 1996 and 2008 were classified according to screening history through a record linkage with the screening programme registry. The incidence significantly decreased from 11.6/100 000 to 8.7/100 000; this decrease is due to a reduction in squamous cell cancers (annual percentage change -6.2; confidence interval: - 7.8, -4.6) and advanced cancers (annual percentage change -6.6; confidence interval: - 8.8, -4.3), whereas adenocarcinomas and microinvasive cancers were essentially stable. The proportion of cancers among women not yet invited and among nonresponders decreased over the two periods, from 45.5 to 33.3%. In contrast, the proportion of women with a previous negative Pap test less than 5 years and 5 years or more before cancer incidence increased from 5.7 to 13.3% and from 0.3 to 5.5%, respectively. Although nonattendance of the screening programme remains the main barrier to cervical cancer control, the introduction of a more sensitive test, such as the human papillomavirus DNA test, could significantly reduce the burden of disease.

AB - Most invasive cervical cancers in industrialized countries are due to the lack of Pap test coverage, very few are due to screening failures. This study aimed at quantifying the proportion of invasive cancers occurring in nonscreened or underscreened women and that in women with a previous negative screening, that is, screening failure, during the first two screening rounds (1996-2002) and in the following rounds (2003-2008) in the Emilia-Romagna region. All cases of invasive cancers registered in the regional cancer registry between 1996 and 2008 were classified according to screening history through a record linkage with the screening programme registry. The incidence significantly decreased from 11.6/100 000 to 8.7/100 000; this decrease is due to a reduction in squamous cell cancers (annual percentage change -6.2; confidence interval: - 7.8, -4.6) and advanced cancers (annual percentage change -6.6; confidence interval: - 8.8, -4.3), whereas adenocarcinomas and microinvasive cancers were essentially stable. The proportion of cancers among women not yet invited and among nonresponders decreased over the two periods, from 45.5 to 33.3%. In contrast, the proportion of women with a previous negative Pap test less than 5 years and 5 years or more before cancer incidence increased from 5.7 to 13.3% and from 0.3 to 5.5%, respectively. Although nonattendance of the screening programme remains the main barrier to cervical cancer control, the introduction of a more sensitive test, such as the human papillomavirus DNA test, could significantly reduce the burden of disease.

KW - Cervical cancer

KW - Human papillomavirus DNA test

KW - Incidence trend

KW - Mass screening

KW - Pap test

UR - http://www.scopus.com/inward/record.url?scp=84927694805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927694805&partnerID=8YFLogxK

U2 - 10.1097/CEJ.0000000000000035

DO - 10.1097/CEJ.0000000000000035

M3 - Article

C2 - 24787379

AN - SCOPUS:84927694805

VL - 24

SP - 128

EP - 134

JO - European Journal of Cancer Prevention

JF - European Journal of Cancer Prevention

SN - 0959-8278

IS - 2

ER -